oxazolidin-2-one has been researched along with adamantane in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Allocco, J; Barrett, J; Bartizal, K; Basilio, A; Becker, JW; Colwell, L; Cully, D; Cummings, R; Dorso, K; Felcetto, T; Galgoci, A; Genilloud, O; Gill, C; Ha, S; Herath, K; Hermes, JD; Hernandez, L; Jayasuriya, H; Kodali, S; Lee, SH; Michael, B; Motyl, M; Ondeyka, J; Painter, R; Parthasarathy, G; Pelaez, F; Schmatz, D; Shoop, W; Silver, LL; Singh, SB; Soisson, SM; Tang, YS; Tormo, JR; Vicente, F; Wang, J; Young, K; Zhang, C | 1 |
| Nuermberger, EL; Spigelman, MK; Yew, WW | 1 |
| Campbell, S; Dubuisson, T; Einck, L; Jakubiec, W; Ladukto, L; Nacy, CA; Reddy, VM; Wallis, RS | 1 |
| Campbell, S; Jakubiec, W; Ladutko, L; Miller, PF; Mitton-Fry, M; Paige, D; Silvia, A; Wallis, RS | 1 |
| Jeong, BH; Koh, WJ; Kwon, YS | 1 |
| Chang, KC; Heyckendorf, J; Lange, C; Olaru, ID; von Groote-Bidlingmaier, F; Yew, WW | 1 |
| Cole, ST; Dhar, N; Hartkoorn, RC; Lechartier, B; Sala, C; Vocat, A; Zhang, M | 1 |
| Nair, SG; Patel, DB; Patel, HD; Rathwa, SK; Vasava, MS | 1 |
| Karkara, BB; Kumar, A; Panda, G | 1 |
5 review(s) available for oxazolidin-2-one and adamantane
| Article | Year |
|---|---|
Current development and future prospects in chemotherapy of tuberculosis.
Topics: Adamantane; Animals; Antitubercular Agents; Carbapenems; Clinical Trials as Topic; Diarylquinolines; Drug Delivery Systems; Ethylenediamines; Fluoroquinolones; Humans; Isonicotinic Acids; Mice; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Patient Compliance; Pyrroles; Quinolines; Rifamycins; Tuberculosis, Pulmonary | 2010 |
Tuberculosis: clinical trials and new drug regimens.
Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2014 |
Novel drugs against tuberculosis: a clinician's perspective.
Topics: Adamantane; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarylquinolines; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Oxazoles; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2015 |
Development of new drug-regimens against multidrug-resistant tuberculosis.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Development; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Ethylenediamines; Humans; Isoniazid; Macrolides; Medication Adherence; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2019 |
Novel candidates in the clinical development pipeline for TB drug development and their synthetic approaches.
Topics: Adamantane; Animals; Antitubercular Agents; DNA Gyrase; Drug Development; Enzyme Inhibitors; Humans; Isonicotinic Acids; Mycobacterium tuberculosis; Oxazolidinones; Piperidines; Pyrroles; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uridine | 2021 |
4 other study(ies) available for oxazolidin-2-one and adamantane
| Article | Year |
|---|---|
Platensimycin is a selective FabF inhibitor with potent antibiotic properties.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Acetamides; Adamantane; Aminobenzoates; Aminoglycosides; Anilides; Animals; Anti-Bacterial Agents; Apoproteins; Bacterial Proteins; Crystallography, X-Ray; Linezolid; Lipids; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Oxazolidinones; Streptomyces; Substrate Specificity | 2006 |
SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro.
Topics: Adamantane; Animals; Antitubercular Agents; Cell Line; Drug Interactions; Ethylenediamines; Macrophages; Mice; Microbial Viability; Mycobacterium tuberculosis; Oxazolidinones | 2012 |
Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Monitoring; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Time Factors | 2012 |
Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.
Topics: Adamantane; Antitubercular Agents; Colony Count, Microbial; Diarylquinolines; Drug Discovery; Ethylenediamines; Genes, Bacterial; Luminescence; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazines; Oxazolidinones; Photorhabdus; Pyrazinamide; Rifamycins; Xanthenes | 2015 |